v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2023
Current Assets:      
Cash and cash equivalents $ 112 $ 112
Inventory 15,339,253 8,268,766
Prepaid expenses 2,700,000 2,700,000 7,734,895
Total Current Assets 18,039,365 10,968,878 7,734,895
Other Assets:      
In-process research and development 73,400,000 73,400,000 40,000,000
Total Other Assets 73,400,000 73,400,000 40,000,000
Total Assets 91,439,365 84,368,878 47,734,895
Current Liabilities:      
Accounts payable 7,676,310 3,711,622 1,289,045
License payable 28,400,000 28,400,000
Accrued expenses 8,722,168 259,071
Total Current Liabilities 49,740,142 32,700,428  
Deferred tax liability 2,256,480 1,728,000 1,152,000
Total Liabilities 55,796,733 38,228,539  
Stockholders’ Equity:      
Preferred stock, value
Common stock, par value 7,155 7,155 6,750
Additional paid-in capital 89,308,821 85,411,771 43,658,750
Accumulated deficit (53,673,344) (39,278,587) (18,129,840)
Total Stockholders’ Equity 35,642,632 46,140,339 25,535,660
Total Liabilities and Stockholders’ Equity 91,439,365 84,368,878 47,734,895
Related Party      
Current Liabilities:      
Due to related party 4,941,664 588,806 19,499,119
Note payable to related party $ 3,800,111 3,800,111
Previously Reported      
Current Liabilities:      
Total Current Liabilities   32,700,429 21,047,235
Total Liabilities   $ 38,228,540 $ 22,199,235